About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

A Single-Center Pilot Study to Assess Macular Function

NCT01204541·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

ORA, Inc.

Age

20–90

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Subjects in good health aged 20-29 or 60-90 years (normal cohorts)
Subjects with early non-exudative age-related macular degeneration (AMD cohort)

You may not be if

Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study

The record

StatusCompleted

PhaseNo phase

Taking part24

StartedSep 2010

UpdatedFeb 14, 2012

Conditions

Macular Degeneration

Where1

Andover, Massachusetts, United States

Clareo Health | A Single-Center Pilot Study to Assess Macular Function